Visceral obesity augments prescription use: An analysis of the cross-sectional study of NHANES 2011–2018
VATob is associated with augmented prescription use, particularly with cardiovascular and metabolic agents. This association was higher for normal weight participants.
Authors
- M. Elba González-Mejía (ORCID: https://orcid.org/0000-0003-2569-1998)
- Enrique Torres‐Rasgado (ORCID: https://orcid.org/0000-0001-5273-4522)
- Esther López‐Bayghen (ORCID: https://orcid.org/0000-0002-2849-7587)
- Leonardo M. Porchia (ORCID: https://orcid.org/0000-0002-4082-7606)
- Maximino Acevedo-Fernández
- Renata Ochoa Precoma
- Victor M. Posadas
Institutions
- Centro de Investigación y de Estudios Avanzados del Instituto Politécnico Nacional (MX)
- Benemérita Universidad Autónoma de Puebla (MX)
Publication Details
- Journal
- PLoS ONE
- Published
- 2025-02-03
- DOI
- https://doi.org/10.1371/journal.pone.0318413
- Primary Topic
- Pharmacology and Obesity Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Vicerrectoría de Investigación y Estudios de Posgrado, Benemérita Universidad Autónoma de Puebla